{"name": "Angioblast Systems",
 "permalink": "angioblast-systems",
 "crunchbase_url": "http://www.crunchbase.com/company/angioblast-systems",
 "homepage_url": "http://www.angioblast.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2001,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@angioblast.com",
 "phone_number": "(212) 880-2060 ",
 "description": "",
 "created_at": "Thu May 13 01:14:06 UTC 2010",
 "updated_at": "Wed Jul 25 08:59:11 UTC 2012",
 "overview": "\u003Cp\u003EAngioblast Systems, Inc., a biotechnology company, engages in the development and commercialization of therapeutic products for the treatment of cardiovascular diseases. It provides adult stem cells, protein therapeutics, gene silencing, small molecule peptides and antibodies, cytokines and antigen-receptor inhibitors, and DNAzymes, as well as MPC products for heart failure, heart attacks, peripheral artery diseases, and wound ulcers. The company has a strategic alliance with Mesoblast Limited. Angioblast Systems, Inc. was founded in 2001 and is headquartered in New York, New York.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0008/6966/86966v1-max-150x150.jpg"],
     [[185,
       62],
      "assets/images/resized/0008/6966/86966v1-max-250x250.jpg"],
     [[185,
       62],
      "assets/images/resized/0008/6966/86966v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Scientific Founder, Chief Scientist, and Chairman of Scientific Advisory Board",
    "person":
     {"first_name": "Silviu",
      "last_name": "Itescu",
      "permalink": "silviu-itescu",
      "image": null}},
   {"is_past": true,
    "title": "CFO",
    "person":
     {"first_name": "Elliott",
      "last_name": "Bendrihem",
      "permalink": "elliott-bendrihem",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": "cash_and_stock",
   "source_url": "http://www.fiercebiotech.com/story/mesoblast-acquire-angioblast-and-speed-stem-cell-work/2010-05-12?utm_medium=rss\u0026utm_source=rss",
   "source_description": "Mesoblast to acquire Angioblast and speed up stem cell work",
   "acquired_year": 2010,
   "acquired_month": 5,
   "acquired_day": 12,
   "acquiring_company":
    {"name": "Mesoblast",
     "permalink": "mesoblast",
     "image":
      {"available_sizes":
        [[[150,
           38],
          "assets/images/resized/0008/6970/86970v2-max-150x150.png"],
         [[250,
           63],
          "assets/images/resized/0008/6970/86970v2-max-250x250.png"],
         [[300,
           76],
          "assets/images/resized/0008/6970/86970v2-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "275 Madison Ave",
    "address2": "4th floor",
    "zip_code": "10016 ",
    "city": "New York",
    "state_code": "NY",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        79],
       "assets/images/resized/0008/6965/86965v1-max-150x150.jpg"],
      [[250,
        132],
       "assets/images/resized/0008/6965/86965v1-max-250x250.jpg"],
      [[450,
        238],
       "assets/images/resized/0008/6965/86965v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}